Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elovainio, M.
Right arrow Articles by Keltikangas-Järvinen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elovainio, M.
Right arrow Articles by Keltikangas-Järvinen, L.
Related Collections
Right arrow Genetics
Right arrow Depression
Right arrow Stress and Coping
Psychosomatic Medicine 69:391-395 (2007)
© 2007 American Psychosomatic Society


ORIGINAL ARTICLES

Genetic Variants in the DRD2 Gene Moderate the Relationship Between Stressful Life Events and Depressive Symptoms in Adults: Cardiovascular Risk in Young Finns Study

Marko Elovainio, PhD, Markus Jokela, MSc, Mika Kivimäki, PhD, Laura Pulkki-Råback, PhD, Terho Lehtimäki, MD, PhD, Nina Airla, MSc and Liisa Keltikangas-Järvinen, PhD

From the Department of Psychology (M.E., M.J., M.K., L.P.-R., L.K.-J.), University of Helsinki, Helsinki, Finland; National Research and Development Center for Welfare and Health (M.E.), Helsinki, Finland; Department of Epidemiology and Public Health (M.E., M.K.), University College London, London, UK; Department of Clinical Chemistry (T.L., N.A.), Tampere University Hospital, Tampere, Finland; Medical School (T.L., N.A.), University of Tampere, Tampere, Finland.

Address correspondence and reprint requests to Liisa Keltikangas-Järvinen. Department of Psychology, P.O. Box 9, FIN-00014, University of Helsinki, Helsinki, Finland. E-mail: Liisa.keltikangas-jarvinen{at}helsinki.fi


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Objective: To examine the potential moderating role of DRD2 polymorphism (rs1800497) in the association between stressful life events and depressive symptoms among young adults. Although stressful life events, such as divorce, unemployment, and serious illness in the family, are generally associated with negative health outcomes, including depressive symptoms, there are large individual differences in coping with such events. A number of studies suggest that variants in dopamine receptor genes, such as DRD2, are associated with depression but it is unclear if such variants also modify the association between life events and depression.

Methods: We analyzed the prospective data on life events and depressive symptoms in 1992 and 2001 related to 1611 young adults (672 men and 939 women, aged 15–30 years at baseline) who participated in the ongoing population-based cardiovascular risk in young Finns study.

Results: Occurrence of stressful life events was associated with increased risk of subsequent depressive symptoms in men and women. However, this association was seen only among those who carried A2/A2 (n = 872) genotype. No such association was detected in participants carrying A1/A1 or A1/A2 (n = 486) genotype.

Conclusion: DRD2 polymorphism moderates the effect of stressful life events on depressive symptoms and those who carry A2/A2 DRD2 genotypes may be more vulnerable than others.

Key Words: genetic • DRD2 • life events • psychosocial • depression

Abbreviations: BMI = body mass index; CHD = coronary heart disease; CRYF = cardiovascular risk in young Finns; CVD = cardiovascular disease; HDL = high-density lipoprotein; LDL = low-density lipoprotein.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
A large body of research suggests that there is a link between stressful life events and later health problems (1–7). Stressful life events are also a potential source of psychological problems. For example, the number of life events, in general, and of specific events categorized as dangers, in particular, has been associated with the onset of anxiety (1), and a variety of different stressful events have been associated with an increased likelihood of depressive symptoms and mental distress (3). Major or cumulative life events have also demonstrated a relationship with health-risk behaviors, such as smoking and alcohol abuse (8). Divorce, being a victim of a crime, and decrease in financial position have been associated with increased prevalence of heavy drinking in men (9) but the evidence is not consistent for other event categories or life events in general (10).

Despite the extensive evidence on the association between life events and health, considerable individual differences in coping with such events have been reported (11). It has been suggested that there are dispositions, such as high optimism, that may protect against the adverse effects of stressful life event but the evidence so far has been mixed and based on self-reported data on both life events and the moderating factor.

The human central dopamingeric system and especially dopamine receptors are widely considered to play an important role in the development of depression, bipolar disorders, and depressive symptoms. Dopamine system has been shown to be involved in determining reactions to environmental stress (12) and some of dopamine reuptake inhibitors show antidepressant effects (13).

A genetic contribution to the etiology of depression has been well established, and the search for specific genetic loci is now underway (14,15). A number of studies have analyzed dopamine receptor genes, including polymorphisms in DRD2, for associations with bipolar disorder and depression or depressive symptoms (16,17). Of special interest is the Taq1A (C32806T) polymorphism, a C to T substitution located in a noncoding region of the DRD2 locus, as this genetic variant has been suggested to affect dopamine receptor D2 availability in postmortem striatal samples (18–20). The A1 (T) allele has also been associated with low dopamine density and lower mean relative glucose metabolic rate in dopaminergic regions in the human brain (20).

The first molecular genetic demonstrations of gene-environment interactions in human behavior evaluated the interaction effect between DRD2 gene polymorphism affecting dopamine receptor availability and family environment (21,22). In a sample of adolescent boys, Berman and Noble (1997) showed that family stress correlated negatively with cognitive functioning in boys carrying the "minor" allele of the DRD2 but not in others. However, it is unclear whether DRD2 polymorphisms may moderate the association between life events and depressive symptoms.

In this study, we longitudinally investigated the potential moderating effect of DRD2 polymorphism between life events and depressive symptoms in early adulthood. We genotyped a population-based sample of men and women, aged 15 to 30 years at baseline, and followed up this group for 9 years to determine the magnitude of the association between life events and depressive symptoms for carriers of each DRD2 polymorphism. Although most of the studies on life events are based on the list of 16 negative life events derived from those used in earlier studies (23,24), we focused on specific categories of particularly stressful major life events: a) death of spouse or child, b) divorce, or c) unemployment. These life events have consistently predicted health problems across a large variety of populations (5,7,25–27). We took into account the effects of other known psychosocial risk factors for depressive symptoms, such as low socioeconomic position in childhood and adulthood and behavioral risks (body mass index, alcohol consumption, and smoking).


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Study Subjects
Selection Procedure and Participants
The participants were derived from the ongoing population-based study of cardiovascular risk in young Finns (CRYF) (28). In this prospective, epidemiological study, a randomized sample of 3600 healthy Finnish children and adolescents in age cohorts of 3, 6, 9, 12, 15, and 18 years has been followed from 1980. During the sixth follow-up of the CRYF in 2001 (21 years after the baseline), 2229 participants were reexamined for adulthood depressive symptoms and DRD2. The sample with complete data consisted of 1636 individuals (683 men and 953 women) who were 3 to18 years of age at the baseline in 1980. Compared with the eligible population at the baseline, the participants in the present sample were more often women ({chi}2 = 110.24; df = 1; p < .001) but other baseline differences were small and not statistically significant. Participants gave written consent, and the study was approved by local ethics committees.

DNA Extraction and DRD2 C32806T (rs1800497) Genotyping
Genomic deoxyribonucleic acid (DNA) was extracted from peripheral blood leukocytes using a commercially available kit and BioRobot M48 Workstation according to the manufacturer's instructions (Qiagen Inc., Hilden, Germany). DRD2 C32806T (rs1800497) was genotyped by employing the 5'exonuclease assay and fluorogenic allele-specific TaqMan MBG probes (29) using the ABI Prism 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA). The nucleotide sequences of primers and probes used in the polymerase chain reaction (PCR) were deduced from published sequences deposited in the GenBank and synthesized in conjugation with Applied Biosystems. PCR reaction mixture consisted of genomic DNA, 1x Universal PCR Master Mix, 900 nM of each primer, and 200 nM of each probe. Amplification was performed using the TaqMan Universal Thermal Cycling Protocol. After PCR, end-point fluorescence intensity was measured and genotype calling was carried out by the allelic discrimination analysis module. As a quality control, random duplicates were run.

Measures
Socioeconomic Position
Parental educational level and their income were requested from both parents of all participants. Three categories of early socioeconomic position were used based on the family income quartiles in 1980: high (highest 25%), medium, and low (lowest 25%). Also, parental education and participants' own education were used. Both parental and participants' own education was categorized into three levels: academic (studying at or graduated from a university); secondary education but not academic (high school or vocational school as their highest education); and comprehensive school (those who had not passed a secondary education). Information on the parent with a higher educational level was used in the analyses.

Health Risk Behavior
The health risk behaviors measured were smoking status (nonsmoker versus current smoker), alcohol consumption (units/week), and body mass index (BMI).

Life Events
Death or serious illness of spouse or children, divorce, and unemployment that occurred from 1992 to 2001 were determined by questionnaire surveys in 1992, 1997, and 2001. In the whole data, the frequencies of these categories were 21, 23, 220, and 1110, which are comparable distributions shown by other Finnish databases. The participants were divided into two groups: those who had experienced any of these event categories and others.

Depressive Symptoms
Depressive symptoms were assessed using a revised version of Beck's Depression Inventory (BDI) (30–32) In the present study, the subjects were asked to rate 21 items (e.g., "I often feel sad") on a 5-point scale ranging from totally disagree (1 point) to totally agree (5 points).

Other measurements included age and gender.

Statistical Analysis
Group differences in the distribution of the DRD2 polymorphism (any A1 genotype versus A2/A2 genotype) and the interaction analyses were analyzed using the analysis of variance and linear multivariate regression analysis. Any A1 genotype group was formed due to the small number of A1/A1 genotypes. Previous studies investigating the effect of DRD2 on various outcomes (depressive symptoms/alcohol consumption) have used similar genotype categories for the same reasons or just compared A2 and A1 alleles (33). Statistical significance was set at p ≤ .05. All regression models were adjusted for age. Statistical analysis was performed using the SAS software (Version 9.1).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
The genotype distributions in men and women followed the Hardy-Weinberg equilibrium (p > .25 and p> .17, respectively). Genotype frequencies were (A2/A2) 357 and (A1/A2 + A1/A1) 205 for men and (A2/A2) 515 and (A1/A2 + A1/A1) 281 for women. There was no significant difference between men and women in the overall genotype distribution ({chi}2 = 0.19; p = .66), family income ({chi}2 = 0.96; p = .61), participants' own education ({chi}2 = 0.97; p = .97), or parental education ({chi}2 = 5.81; p = .06). Women had significantly higher level of depressive symptoms in 1992 (t(1266) = 5.51; p > .001) and in 2001 (t(1609) = 5.67; p < .001) compared with men. Women had experienced life events slightly more often than men ({chi}2 = 4.71; p = .030). Men had higher BMI (t(1514) = –6.78; p < .001), smoked more often ({chi}2 = 10.64; p < .01), and consumed more alcohol (t(1266) = 15.67; p < .001) than women (Table 1).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Sample Characteristics

 

There were no statistically significant interaction effects between gender and life events on depressive symptoms in 1992 (F(4,1267) = 0.58; p = .45) or in 2001 (F(4,1610) = 0.00; p = .97). Thus, the regression analyses were conducted for men and women in combination. Of the potential confounding variables, such as parental education, family income, education, BMI, smoking, and alcohol consumption, only BMI was related to depressive symptoms in adulthood (p < .001) after adjustments for age, gender, and baseline (1992) depressive symptoms. Occurrence of life events was associated with increased adulthood depressive symptoms when adjusted for age, gender, and baseline depressive symptoms (p = .01). There was no significant association between DRD2 polymorphism and depressive symptoms (Table 2).


View this table:
[in this window]
[in a new window]

 
TABLE 2. Standardized ß Coefficients From Linear Models for Depressive Symptoms in 2001 and Early and Adulthood Risk Factors in Men and Women Adjusted for Age, Gender, and Previous (1992) Depressive Symptoms

 

The interaction effect between DRD2 polymorphism and life events on depressive symptoms in 2001 was statistically significant (F(4,1610) = 4.84; p = .03) and this effect was robust to adjustments for the covariates (Table 3). The age, gender, and baseline-adjusted association between life events and depressive symptoms in 2001 was significant only in those who carried the A2/A2 genotype (ß = 0.11; p < .01). This association was robust to adjustment for any of the confounding factors. In the A1/A2 + A1/A1 genotype group, the association was weaker and statistically nonsignificant (ß = 0.03; p = .56) (Table 4). The mean values of depressive symptoms among those with and without life events according to DRD2 genotype are presented in Figure 1.


View this table:
[in this window]
[in a new window]

 
TABLE 3. Interaction Effect of DRD2 and Life Events on Depressive Symptoms in 2001 (Standardized ß Coefficients, n = 1225)

 

View this table:
[in this window]
[in a new window]

 
TABLE 4. Multiple Linear Regression Analyses for Depressive Symptoms in 2001 and Life Events in DRD2 Genotype Groups

 

Figure 11
View larger version (18K):
[in this window]
[in a new window]

 
Figure 1. Depressive symptoms among those with and without life events according to DRD2 genotype.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
We found a weak overall association of experiencing life events, such as serious illness or death in the family, divorce, or unemployment, and subsequent higher depressive symptoms among young adults. However, this association masked a gene-environment interaction by Taq1A (C32806T, SNP rs1800497) polymorphism in DRD2 gene with a stronger association among those who carried the A2/A2 genotype and a weaker association among other genotypes. The results of this study are in line with the previous ones, suggesting that experiencing stressful life events affects later depression. Our results also suggest that there are genetic factors that intensify or protect from later depressive symptoms among those exposed to stressful environmental conditions. More specifically, we found that variants in genes regulating the D2 dopamine receptors may modify the impact of life events on depressive symptoms.

Our results are in line with the previous results, suggesting a role of the DRD2 in the development of depressive symptoms. For example, Berman and colleagues (33) found that those boys of alcoholics carrying the A2/A2 genotype scored higher on BDI than those carrying any A1 genotype. According to the results of Lawford and co-workers (34), those patients of posttraumatic disorders with DRD2 A1/A2 genotype compared with those with the A2/A2 genotype had higher depression scores at baseline but they showed a significantly greater improvement in social functioning after paroxetine treatment compare with those having the A2/A2 genotype.

Berman and Noble (21) showed that family stress correlated negatively with cognitive functioning in boys carrying the A1 allele of the DRD2, but not in others. In the same sample, Ozkaragoz and Noble (22) reported that the association between parental alcoholism and extraversion was moderated by the DRD2, such that living in an alcoholic home was associated with high extraversion among boys carrying the A1 allele of the DRD2, but not among those carrying the A2 allele. Extraversion has, in turn, been associated with low depressive symptoms (35). Similarly, it has been found that the A1 allele has been associated with temperament dimension novelty seeking (36) and lower risk of depressive symptoms (37). Madrid and others (38), in turn, found the association between experienced economic stress and alcoholism to be moderated by the DRD2 polymorphism, so that the association was stronger in those carrying the A1 alleles. All these findings are consistent with the gene-environment interactions observed in this study.

In previous studies, the A1 + allele and the A1/A1 + A1/A2 genotype have shown a small main effect on emotional disorders, especially in non-Caucasian samples (39). However, because of their diminished brain dopaminergic reward system (40), it has been suggested (33) that boys with the A1/A1 + A1/A2 genotype have lower tolerance for experiencing negative effect than boys with the A2/A2 genotype and, consequently, develop better coping mechanisms to maintain their emotional balance during stressful life events.

It should be noted that the variant of the DRD2 gene focused in this study has been shown to have functional significance, as subjects carrying the DRD2 A1 allele, compared with findings for those without this allele, have reduced brain D2 dopamine receptors (18,20). Both animal and human studies implicate the D2 dopamine receptor (DRD2) gene in the pathogenesis of anxiety and depression. However, evidence on the interaction effects between environmental factors and genetic vulnerability in explaining emotional disorders, such as depressive symptoms, is still scarce and the final conclusions are not yet drawn.

Comparable results to ours, however, have been found on the interaction effect of serotonin transporter genes and life events on severity of depression. According to the results of Zalsman and others (41), lower expressing alleles of 5 HTTLPR predicted greater severity of major depression with moderate-to-severe life events compared with the higher expressing allele.

In interpreting the present results, it is important to note some limitations. Although the design of the CRYF study is population-based, the sample was restricted to men and women aged 15 to 30 years at baseline. The measure of depressive symptoms used in this study was a revised version of the widely used BDI. The subjects were asked to rate on a 5-point scale the second mildest BDI statements, which were suggested to be the most effective ones for measuring depressive symptoms in the normal population (42,43). Thus, a study replicating our project and using standard response format would offer an interesting comparison to the present results and would help to define the clinical significance of our findings.

We conclude that, although it is possible that a single gene plays a major role in determining susceptibility, the majority of depressive disorder involves more complex genetic mechanisms, such as the interaction of multiple genes and environmental factors. Molecular genetic positional and candidate gene approaches are being used for the genetic dissection of depressive disorder. Our results now suggest that DRD2 may be one of such candidate genes that acts as a vulnerability factor and at the same time interacts with risky environment.


    NOTES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Received for publication November 29, 2006; revision received March 7, 2007.

This study was financially supported by the Signe and Ane Gyllenberg's Foundation (L.K.-J.); Grants 209514 (L.K.-J.), 209518 (L.K.-J.), 111056 (L.K.-J.), and 117604 (M.K.) from the Academy of Finland; Emil Aaltonen Foundation (T.L.); and Tampere University Hospital Medical Fund (T.L.).

DOI:10.1097/psy.0b013e31806bf365


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 

  1. Brown GW, Harris TO, Eales MJ. Aetiology of anxiety and depressive disorders in an inner-city population. 2. Comorbidity and adversity. Psychol Med 1993;23:155–65.[Medline]
  2. Kendler KS, Walters EE, Kessler RC. The prediction of length of major depressive episodes: results from an epidemiological sample of female twins. Psychol Med 1997;27:107–17.[CrossRef][Medline]
  3. Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol 1997;48:191–214.[CrossRef][Medline]
  4. Kaprio J, Koskenvuo M, Langinvainio H, Romanov K, Sarna S, Rose RJ. Social and genetic influences on drinking patterns of adult men: a study of 5638 Finnish twin brothers. Alcohol Alcohol Suppl 1987;1:373–7.[Medline]
  5. Li J, Precht DH, Mortensen PB, Olsen J. Mortality in parents after death of a child in Denmark: a nationwide follow-up study. Lancet 2003;361:363–7.[CrossRef][Medline]
  6. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991;325:606–12.[Abstract]
  7. Kivimäki M, Vahtera J, Elovainio M, Lillrank B, Kevin MV. Death or illness of a family member, violence, interpersonal conflict, and financial difficulties as predictors of sickness absence: longitudinal cohort study on psychological and behavioral links. Psychosom Med 2002;64:817–25.[Abstract/Free Full Text]
  8. Kivimäki M, Vahtera J, Pentti J, Ferrie JE. Factors underlying the effect of organisational downsizing on health of employees: longitudinal cohort study. BMJ 2000;320:971–5.[Abstract/Free Full Text]
  9. Jose BS, van Oers HA, van de Mheen HD, Garretsen HF, Mackenbach JP. Stressors and alcohol consumption. Alcohol Alcohol 2000;35:307–12.[Abstract/Free Full Text]
  10. Goldstein BI, Abela JR, Buchanan GM, Seligman ME. Attributional style and life events: a diathesis-stress theory of alcohol consumption. Psychol Rep 2000;87:949–55.[Medline]
  11. Kivimäki M, Elovainio M, Kokko K, Pulkkinen L, Kortteinen M, Tuomikoski H. Hostility, unemployment and health status: testing three theoretical models. Soc Sci Med 2003;56:2139–52.[CrossRef][Medline]
  12. Pani L, Porcella A, Gessa GL. The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry 2000;5:14–21.[CrossRef][Medline]
  13. Paes de Sousa M, Tropa J. Evaluation of the efficacy of amineptine in a population of 1,229 depressed patients: results of a multicenter study carried out by 135 general practitioners. Clin Neuropharmacol 1989;12(Suppl 2):S77–S86.[Medline]
  14. Baron M. Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 2002;7:342–58.[CrossRef][Medline]
  15. Morley KI, Hall WD, Carter L. Genetic screening for susceptibility to depression: can we and should we? Aust N Z J Psychiatry 2004;38:73–80.[CrossRef][Medline]
  16. Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, Van Broeckhoven C, Mendlewicz J. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Med Genet 1996;67:551–5.[CrossRef][Medline]
  17. Stober G, Jatzke S, Heils A, Jungkunz G, Knapp M, Mossner R, Riederer P, Lesch KP. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication. J Neural Transm 1998;105:101–9.[CrossRef][Medline]
  18. Noble F, Cox BM. The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment. J Pharmacol Exp Ther 1997;283:557–65.[Abstract/Free Full Text]
  19. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997;7:479–84.[CrossRef][Medline]
  20. Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC. D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 1997;74:162–6.[CrossRef][Medline]
  21. Berman SM, Noble EP. The D2 dopamine receptor (DRD2) gene and family stress; interactive effects on cognitive functions in children. Behav Genet 1997;23:117–22.[CrossRef]
  22. Ozkaragoz T, Noble EP. Extraversion. Interaction between D2 dopamine receptor polymorphisms and parental alcoholism. Alcohol 2000;22:139–46.[CrossRef][Medline]
  23. Dohrenwend BS, Krasnoff L, Askenasy AR, Dohrenwend BP. Exemplification of a method for scaling life events: the Peri Life Events Scale. J Health Soc Behav 1978;19:205–29.[CrossRef][Medline]
  24. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res 1967;11:213–8.[CrossRef][Medline]
  25. Levav I, Krasnoff L, Dohrenwend BS. Israeli PERI life event scale: ratings of events by a community sample. Isr J Med Sci 1981;17:176–83.[Medline]
  26. Martikainen PT, Valkonen T. The effects of differential unemployment rate increases of occupation groups on changes in mortality. Am J Public Health 1998;88:1859–61.[Abstract/Free Full Text]
  27. Vance JC, Foster WJ, Najman JM, Embelton G, Thearle MJ, Hodgen FM. Early parental responses to sudden infant death, stillbirth or neonatal death. Med J Aust 1991;155:292–7.[Medline]
  28. Åkerblom HK, Uhari M, Pesonen E, Dahl M, Kaprio EA, Nuutinen EM, Pietikäinen M, Salo MK, Aromaa A, Kannas L, Keltikangas-Järvinen L, Kuusela V, Räsä nen L, Rönnemaa T, Knip M, Telama R, Välimäki I, Pyörälä K, Viikari J. Cardiovascular risk in young Finns. Ann Med 1991;23:35–9.[Medline]
  29. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999;14:143–9.[Medline]
  30. Beck A. Depression. Clinical, experimental and theoretical aspects. New York: Harper & Row Publishers; 1967.
  31. Steer RA, Beck AT, Brown G, Berchick RJ. Self-reported depressive symptoms that differentiate recurrent-episode major depression from dysthymic disorders. J Clin Psychol 1987;43:246–50.[CrossRef][Medline]
  32. Katainen S, Räikkönen K, Keltikangas-Järvinen L. Adolescent temperament, perceived social support, and depressive tendencies as predictors of depressive tendencies in young adulthood. European Journal of Personality 1999;13:183–207.[CrossRef]
  33. Berman SM, Ozkaragoz T, Noble EP, Antolin T, Sheen C, Siddarth P, Conner BT, Ritchie T. Differential associations of sex and D2 dopamine receptor (DRD2) genotype with negative affect and other substance abuse risk markers in children of alcoholics. Alcohol 2003;30:201–10.[CrossRef][Medline]
  34. Lawford BR, McD Young R, Noble EP, Kann B, Arnold L, Rowell J, Ritchie TL. D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder. Eur Neuropsychopharmacol 2003;13:313–20.[CrossRef][Medline]
  35. Jylhä P, Isometsä E. The relationship of neuroticism and extraversion to symptoms of anxiety and depression in the general population. Depress Anxiety 2006;23:281–9.[CrossRef][Medline]
  36. Noble EP, Ozkaragoz TZ, Ritchie TL, Zhang X, Belin TR, Sparkes RS. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet 1998;81:257–67.[CrossRef][Medline]
  37. Elovainio M, Kivimäki M, Puttonen S, Heponiemi T, Pulkki L, Keltikangas-Järvinen L. Temperament and depressive symptoms: a population-based longitudinal study on Cloninger's psychobiological temperament model.[Comment]. J Affect Disord 2004;83:227–32.[CrossRef][Medline]
  38. Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE. Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism. Alcohol 2001;23:117–22.[CrossRef][Medline]
  39. Li T, Liu X, Sham PC, Aitchison KJ, Cai G, Arranz MJ, Deng H, Liu J, Kirov G, Murray RM, Collier DA. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Res 1999;86:193–201.[CrossRef][Medline]
  40. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 2003;116:103–25.[Medline]
  41. Zalsman G, Huang Yy, Oquendo MA, Burke AK, Hu X, Brent DA, Ellis SP, Goldman D, Mann JJ. Association of a Triallic serotonin transporter gene promotor region (5HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 2006;163:1588–93.[Abstract/Free Full Text]
  42. Elovainio M, Kivimäki M, Puttonen S, Heponiemi T, Pulkki L, Keltikangas-Järvinen L. Temperament and depressive symptoms: a population-based longitudinal study on Cloninger's psychobiological temperament model. J Affect Disord 2004;83:227–32.[CrossRef][Medline]
  43. Salmela-Aro K, Nurmi JE, Saisto T, Halmesmäki E. Goal reconstruction and depressive symptoms during the transition to motherhood: evidence from two cross-lagged longitudinal studies. J Pers Soc Psychol 2001;81:1144–59.[CrossRef][Medline]



This article has been cited by other articles:


Home page
CMAJHome page
M. aan het Rot PhD, S. J. Mathew MD, and D. S. Charney MD
Neurobiological mechanisms in major depressive disorder
Can. Med. Assoc. J., February 3, 2009; 180(3): 305 - 313.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
K. E. Freedland, E. J.C. de Geus, R. N. Golden, W. J. Kop, G. E. Miller, V. Vaccarino, B. Brumback, M. M. Llabre, V. J. White, and D. S. Sheps
What's in a Name? Psychosomatic Medicine and Biobehavioral Medicine
Psychosom Med, January 1, 2009; 71(1): 1 - 4.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Vulnerability to Depressive Symptoms After Adverse Life Events
Journal Watch Psychiatry, August 6, 2007; 2007(806): 4 - 4.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elovainio, M.
Right arrow Articles by Keltikangas-Järvinen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elovainio, M.
Right arrow Articles by Keltikangas-Järvinen, L.
Related Collections
Right arrow Genetics
Right arrow Depression
Right arrow Stress and Coping


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS